| Real-time RT-PCR in COVID-19 detection: issues affecting the results A Tahamtan, A Ardebili Expert review of molecular diagnostics 20 (5), 453-454, 2020 | 1317 | 2020 |
| Anti-inflammatory microRNAs and their potential for inflammatory diseases treatment A Tahamtan, M Teymoori-Rad, B Nakstad, V Salimi Frontiers in immunology 9, 337488, 2018 | 320 | 2018 |
| Health system performance in Iran: a systematic analysis for the Global Burden of Disease Study 2019 F Farzadfar, M Naghavi, SG Sepanlou, SS Moghaddam, WJ Dangel, ... The Lancet 399 (10335), 1625-1645, 2022 | 161 | 2022 |
| Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019 HH Kyu, A Vongpradith, SB Sirota, A Novotney, CE Troeger, MC Doxey, ... The Lancet infectious diseases 22 (11), 1626-1647, 2022 | 101 | 2022 |
| COVID-19: Why does disease severity vary among individuals? S Samadizadeh, M Masoudi, M Rastegar, V Salimi, MB Shahbaz, ... Respiratory Medicine 180, 106356, 2021 | 79 | 2021 |
| Effects of cannabinoids and their receptors on viral infections A Tahamtan, M Tavakoli‐Yaraki, TP Rygiel, T Mokhtari‐Azad, V Salimi Journal of Medical Virology 88 (1), 1-12, 2016 | 62 | 2016 |
| Antitumor effect of therapeutic HPV DNA vaccines with chitosan-based nanodelivery systems A Tahamtan, A Ghaemi, A Gorji, HR Kalhor, A Sajadian, A Tabarraei, ... Journal of biomedical science 21, 1-10, 2014 | 59 | 2014 |
| Effects of cannabinoid receptor type 2 in respiratory syncytial virus infection in human subjects and mice A Tahamtan, Y Samieipoor, FS Nayeri, AA Rahbarimanesh, A Izadi, ... Virulence 9 (1), 217-230, 2018 | 58 | 2018 |
| Opioids and viral infections: a double-edged sword A Tahamtan, M Tavakoli-Yaraki, T Mokhtari-Azad, M Teymoori-Rad, ... Frontiers in microbiology 7, 970, 2016 | 57 | 2016 |
| The role of microRNAs in respiratory viral infection: friend or foe? A Tahamtan, CS Inchley, M Marzban, M Tavakoli‐Yaraki, ... Reviews in Medical Virology 26 (6), 389-407, 2016 | 51 | 2016 |
| An overview of history, evolution, and manufacturing of various generations of vaccines A Tahamtan, J Charostad, SJH Shokouh, M Barati Journal of Archives in Military Medicine 5 (3), 2017 | 46 | 2017 |
| Opioids/cannabinoids as a potential therapeutic approach in COVID-19 patients A Tahamtan, M Tavakoli-Yaraki, V Salimi Expert review of respiratory medicine 14 (10), 965-967, 2020 | 37 | 2020 |
| Disease severity in respiratory syncytial virus infection: role of host genetic variation A Tahamtan, FS Askari, L Bont, V Salimi Reviews in medical virology 29 (2), e2026, 2019 | 37 | 2019 |
| Ten challenging questions about SARS-CoV-2 and COVID-19 M Teymoori-Rad, S Samadizadeh, A Tabarraei, A Moradi, MB Shahbaz, ... Expert review of respiratory medicine 14 (9), 881-888, 2020 | 36 | 2020 |
| Evaluation of the expression level of 12/15 lipoxygenase and the related inflammatory factors (CCL5, CCL3) in respiratory syncytial virus infection in mice model V Salimi, A Ramezani, H Mirzaei, A Tahamtan, E Faghihloo, F Rezaei, ... Microbial pathogenesis 109, 209-213, 2017 | 36 | 2017 |
| An overview of hepatitis B virus surface antigen secretion inhibitors A Mohebbi, N Lorestani, A Tahamtan, NL Kargar, A Tabarraei Frontiers in Microbiology 9, 350286, 2018 | 31 | 2018 |
| Chitosan nanoparticles as a potential nonviral gene delivery for HPV-16 E7 into mammalian cells A Tahamtan, A Tabarraei, A Moradi, M Dinarvand, M Kelishadi, A Ghaemi, ... Artificial cells, nanomedicine, and biotechnology 43 (6), 366-372, 2015 | 27 | 2015 |
| Respiratory syncytial virus infection: why does disease severity vary among individuals? A Tahamtan, S Samadizadeh, M Rastegar, B Nakstad, V Salimi Expert review of respiratory medicine 14 (4), 415-423, 2020 | 25 | 2020 |
| The role of cannabinoid receptor 1 in the immunopathology of respiratory syncytial virus A Tahamtan, M Tavakoli-Yaraki, A Shadab, F Rezaei, SM Marashi, ... Viral Immunology 31 (4), 292-298, 2018 | 25 | 2018 |
| Antitumor immunity induced by genetic immunization with chitosan nanoparticle formulated adjuvanted for HPV-16 E7 DNA vaccine A Tahamtan, M Barati, A Tabarraei, SR Mohebbi, S Shirian, A Gorji, ... Iranian Journal of Immunology 15 (4), 269-280, 2018 | 24 | 2018 |
Vahid SalimiProfessor at Tehran University of Medical SciencesVerified email at sina.tums.ac.ir
